Trauma patients on anticoagulation therapy present unique challenges in clinical management due to the risk of uncontrolled bleeding. The pharmaceutical industry has developed specific reversal agents for many anticoagulants; however, these agents come with their own risks and limitations. Thromboelastography (TEG) is emerging as a best practice in guiding transfusion strategies by providing real-time, individualized assessments of coagulation status. This approach enables clinicians to determine the most appropriate blood products needed to restore hemostatic balance in trauma patients, ultimately improving patient outcomes.
Learning Outcomes:
- Identify and compare various anticoagulation agents
- Explain strategies for reversing anticoagulation in trauma patients
- Evaluate the use of thromboelastography in the management of trauma patients
Members who are logged will be provided with a CE Credit link (below) for the duration of 3 years from the original presentation date (noted above). After 3 years, CE will no longer be made available. Members however are still welcome to watch the presentation independently for non-CE credit.
PLEASE LOGIN
Speaker(s):Jenna Sorgenfrei, PharmD, MSPS, BCCCP is the clinical pharmacy specialist in the surgical trauma ICU at Prisma Health-Upstate Greenville Memorial Hospital. She obtained a Bachelor of Science in Chemistry and Biochemistry from Elmira College in Elmira, NY. Jenna graduated from Campbell University College of Pharmacy and Health Sciences in 2014 with her Doctor of Pharmacy and Master of Science in Pharmaceutical Sciences. She went on to complete a PGY1 Acute Care pharmacy residency at Novant Health New Hanover Regional Medical Center and a PGY2 Critical Care pharmacy residency at Prisma Health-Upstate. Jenna is a Board-Certified Critical Care Pharmacist (BCCCP) and rounds with the surgical critical care team. She also serves as the Residency Program Coordinator for the PGY2 Critical Care residency program
